A major medical device manufacturer requested a recommendation for improving its ability to select statistically valid sampling plans for Design Verification activity supporting its new product in development.  An assessment determined several opportunities for improvement including clearly delineated design verification requirements; identification of risk classification; leverage of legacy acceptance criteria; new acceptance criteria with statistical rationale.  The output of this database was valuable in planning and writing the appropriate design verification protocols.